Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?
De Ruysscher D, Van Meerbeeck J, Vandecasteele K, Oberije C, Pijls M, Dingemans AM, Reymen B, van Baardwijk A, Wanders R, Lammering G, Lambin P, De Neve W. De Ruysscher D, et al. Among authors: wanders r. Strahlenther Onkol. 2012 Jul;188(7):564-7. doi: 10.1007/s00066-012-0098-z. Epub 2012 Apr 29. Strahlenther Onkol. 2012. PMID: 22543884 Clinical Trial.
Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients.
De Ruysscher D, Dehing C, Bremer RH, Bentzen SM, Koppe F, Pijls-Johannesma M, Harzée L, Minken A, Wanders R, Hochstenbag M, Dingemans AM, Boersma L, van Haren E, Geraedts W, Pitz C, Simons J, Wouters B, Rosier JF, Lambin P. De Ruysscher D, et al. Among authors: wanders r. Ann Oncol. 2007 May;18(5):909-16. doi: 10.1093/annonc/mdm005. Epub 2007 Feb 23. Ann Oncol. 2007. PMID: 17322546 Free article.
Total gross tumor volume is an independent prognostic factor in patients treated with selective nodal irradiation for stage I to III small cell lung cancer.
Reymen B, Van Loon J, van Baardwijk A, Wanders R, Borger J, Dingemans AM, Bootsma G, Pitz C, Lunde R, Geraedts W, Lambin P, De Ruysscher D. Reymen B, et al. Among authors: wanders r. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1319-24. doi: 10.1016/j.ijrobp.2012.10.003. Epub 2012 Nov 29. Int J Radiat Oncol Biol Phys. 2013. PMID: 23200174
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study.
De Ruysscher D, Botterweck A, Dirx M, Pijls-Johannesma M, Wanders R, Hochstenbag M, Dingemans AM, Bootsma G, Geraedts W, Simons J, Pitz C, Lambin P. De Ruysscher D, et al. Among authors: wanders r. Ann Oncol. 2009 Jan;20(1):98-102. doi: 10.1093/annonc/mdn559. Epub 2008 Aug 20. Ann Oncol. 2009. PMID: 18718891 Free article.
Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.
De Ruysscher D, Pijls-Johannesma M, Bentzen SM, Minken A, Wanders R, Lutgens L, Hochstenbag M, Boersma L, Wouters B, Lammering G, Vansteenkiste J, Lambin P. De Ruysscher D, et al. Among authors: wanders r. J Clin Oncol. 2006 Mar 1;24(7):1057-63. doi: 10.1200/JCO.2005.02.9793. J Clin Oncol. 2006. PMID: 16505424
Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
van Baardwijk A, Bosmans G, Bentzen SM, Boersma L, Dekker A, Wanders R, Wouters BG, Lambin P, De Ruysscher D. van Baardwijk A, et al. Among authors: wanders r. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1103-10. doi: 10.1016/j.ijrobp.2007.11.028. Epub 2008 Feb 6. Int J Radiat Oncol Biol Phys. 2008. PMID: 18258382 Clinical Trial.
Dyspnea evolution after high-dose radiotherapy in patients with non-small cell lung cancer.
De Ruysscher D, Dehing C, Yu S, Wanders R, Ollers M, Dingemans AM, Bootsma G, Hochstenbag M, Geraedts W, Pitz C, Simons J, Boersma L, Borger J, Dekker A, Lambin P. De Ruysscher D, et al. Among authors: wanders r. Radiother Oncol. 2009 Jun;91(3):353-9. doi: 10.1016/j.radonc.2008.10.006. Epub 2008 Nov 13. Radiother Oncol. 2009. PMID: 19012981
Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study.
De Ruysscher D, Houben A, Aerts HJ, Dehing C, Wanders R, Ollers M, Dingemans AM, Hochstenbag M, Boersma L, Borger J, Dekker A, Lambin P. De Ruysscher D, et al. Among authors: wanders r. Radiother Oncol. 2009 Jun;91(3):415-20. doi: 10.1016/j.radonc.2009.01.004. Epub 2009 Feb 3. Radiother Oncol. 2009. PMID: 19195730
Can we optimize chemo-radiation and surgery in locally advanced stage III non-small cell lung cancer based on evidence from randomized clinical trials? A hypothesis-generating study.
De Ruysscher D, Dehing C, Bentzen SM, Houben R, Dekker A, Wanders R, Borger J, Hochstenbag M, Boersma L, Geskes G, Dingemans AM, Bootsma G, Lammering G, Lambin P. De Ruysscher D, et al. Among authors: wanders r. Radiother Oncol. 2009 Dec;93(3):389-95. doi: 10.1016/j.radonc.2009.06.004. Epub 2009 Jul 1. Radiother Oncol. 2009. PMID: 19576645 Review.
1,110 results